AP 1903 reagent

Known as: AP-1903, AP1903 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2016
024619982016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Activation of the inducible caspase 9 (iC9) safety gene by a dimerizing drug (chemical inducer of dimerization (CID) AP1903… (More)
Is this relevant?
2015
2015
To test the feasibility of a single T-cell manipulation to eliminate alloreactivity while sparing antiviral and antitumor T cells… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2015
2015
The high risk of insertional oncogenesis reported in clinical trials using integrating retroviral vectors to genetically modify… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2014
2014
Induced pluripotent stem cell (iPSC) therapies offer a promising path for patient-specific regenerative medicine. However, tumor… (More)
Is this relevant?
Review
2014
Review
2014
Immune modulation has become a central element in many cancer treatments, and T cells genetically engineered to express chimeric… (More)
  • table 1
  • figure 1
Is this relevant?
2011
2011
The in vivo therapeutic efficacy of DC-based cancer vaccines is limited by suboptimal DC maturation protocols. Although delivery… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
176 Background: We report evidence of antigen-specific immunity and severe prostate cancer inflammation and necrosis after… (More)
Is this relevant?
2011
2011
132 Background: We report results of a phase I/II clinical trial of BPX-101, a drug- activated autologous DC vaccine targeting… (More)
Is this relevant?
2003
2003
New synthetic chemical inducers of dimerization, comprising homodimeric FKBP ligands with engineered specificity for the designed… (More)
Is this relevant?
2001
2001
AP1903 is a novel gene-targeted drug that is being developed for use in drug-regulated cell therapies. An intravenous, single… (More)
Is this relevant?